These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9668222)

  • 1. Molecular and antigenic structure of nicotinic acetylcholine receptors.
    Lindstrom J; Peng X; Kuryatov A; Lee E; Anand R; Gerzanich V; Wang F; Wells G; Nelson M
    Ann N Y Acad Sci; 1998 May; 841():71-86. PubMed ID: 9668222
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic structure of the muscle nicotinic acetylcholine receptor.
    Tzartos SJ; Cung MT; Mamalaki A; Marraud M; Papanastasiou D; Sakarellos C; Sakarellos-Daitsiotis M; Tsantili P
    Ann Med Interne (Paris); 1996; 147(6):442-6. PubMed ID: 9092347
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of experimental autoimmune myasthenia gravis by synthetic peptides of the acetylcholine receptor.
    Souroujon MC; Carmon S; Fuchs S
    Ann N Y Acad Sci; 1993 Jun; 681():332-4. PubMed ID: 8357185
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

  • 5. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
    Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function.
    Vincent A; Li Z; Hart A; Barrett-Jolley R; Yamamoto T; Burges J; Wray D; Byrne N; Molenaar P; Newsom-Davis J
    Ann N Y Acad Sci; 1993 Jun; 681():529-38. PubMed ID: 8395163
    [No Abstract]   [Full Text] [Related]  

  • 8. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
    Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
    Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic structure of the human muscle nicotinic acetylcholine receptor main immunogenic region.
    Luo J; Lindstrom J
    J Mol Neurosci; 2010 Jan; 40(1-2):217-20. PubMed ID: 19705087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune diseases involving nicotinic receptors.
    Lindstrom J
    J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunogenic self-peptide for T cells in mice with experimental myasthenia.
    Xu Q; Agius M; Gudipati E; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1993 Jun; 681():1-4. PubMed ID: 8357155
    [No Abstract]   [Full Text] [Related]  

  • 14. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK
    Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrophysiological characteristics in seronegative myasthenia gravis.
    Oh SJ
    Ann N Y Acad Sci; 1993 Jun; 681():584-7. PubMed ID: 8357205
    [No Abstract]   [Full Text] [Related]  

  • 16. [Autoantibodies in Myasthenia Gravis].
    Higuchi O
    Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis.
    Stefansson K; Dieperink ME; Richman DP; Gomez CM; Marton LS
    N Engl J Med; 1985 Jan; 312(4):221-5. PubMed ID: 2578213
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis.
    Oger JJ
    Ann N Y Acad Sci; 1993 Jun; 681():110-2. PubMed ID: 8357159
    [No Abstract]   [Full Text] [Related]  

  • 19. The nicotinic acetylcholine receptor: structure and autoimmune pathology.
    Conti-Tronconi BM; McLane KE; Raftery MA; Grando SA; Protti MP
    Crit Rev Biochem Mol Biol; 1994; 29(2):69-123. PubMed ID: 8026215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative responses to acetylcholine receptor peptides in myasthenia gravis.
    Berrih-Aknin S; Cohen-Kaminsky S; Neumann D; Bach JF; Fuchs S
    Ann N Y Acad Sci; 1988; 540():504-5. PubMed ID: 2462824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.